Jay Duffner
Director & Head of Discovery Biology Frontier Medicines
Seminars
Thursday 22nd October 2026
Strategic Deployment of Kinetic Assay Technologies to Accelerate Covalent Drug Discovery
10:00 am
- Balancing throughput, cost, and data quality when selecting kinetic potency assay for early-stage covalent discovery
- Designing kinetic and dose-response assays to support efficient lead generation across diverse activity profiles
- Adapting assay platforms throughout lead optimization to accurately evaluate increasingly potent covalent compounds
